143 related articles for article (PubMed ID: 8873557)
1. Inhibition of endogenous nitric oxide synthase potentiates nitrovasodilators in experimental pulmonary hypertension.
Kavanagh BP; Thompson JS; Pearl RG
Anesthesiology; 1996 Oct; 85(4):860-6. PubMed ID: 8873557
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of endogenous nitric oxide synthesis potentiates the effects of sodium nitroprusside but not of adenosine in experimental pulmonary hypertension.
Wall MH; Patterson KW; Kavanagh BP; Pearl RG
Pharmacology; 1999 Jan; 58(1):34-43. PubMed ID: 9831829
[TBL] [Abstract][Full Text] [Related]
3. Pulmonary and systemic vasodilator responses to the soluble guanylyl cyclase stimulator, BAY 41-8543, are modulated by nitric oxide.
Badejo AM; Nossaman VE; Pankey EA; Bhartiya M; Kannadka CB; Murthy SN; Nossaman BD; Kadowitz PJ
Am J Physiol Heart Circ Physiol; 2010 Oct; 299(4):H1153-9. PubMed ID: 20639220
[TBL] [Abstract][Full Text] [Related]
4. Sildenafil is a pulmonary vasodilator in awake lambs with acute pulmonary hypertension.
Weimann J; Ullrich R; Hromi J; Fujino Y; Clark MW; Bloch KD; Zapol WM
Anesthesiology; 2000 Jun; 92(6):1702-12. PubMed ID: 10839922
[TBL] [Abstract][Full Text] [Related]
5. Role of potassium channels and nitric oxide in the effects of iloprost and prostaglandin E1 on hypoxic vasoconstriction in the isolated perfused lung of the rat.
Dumas M; Dumas JP; Rochette L; Advenier C; Giudicelli JF
Br J Pharmacol; 1997 Feb; 120(3):405-10. PubMed ID: 9031743
[TBL] [Abstract][Full Text] [Related]
6. Inhaled nitric oxide potentiates actions of adenosine but not of sodium nitroprusside in experimental pulmonary hypertension.
Patterson KW; Deb B; Kavanagh BP; Pearl RG
Pharmacology; 1999 May; 58(5):246-51. PubMed ID: 10087465
[TBL] [Abstract][Full Text] [Related]
7. Nitric oxide regulation of TP receptor-mediated pulmonary vasoconstriction in the anesthetized, open-chest rat.
Valentin JP; Bessac AM; Maffre M; John GW
Eur J Pharmacol; 1996 Dec; 317(2-3):335-42. PubMed ID: 8997619
[TBL] [Abstract][Full Text] [Related]
8. Involvement of functional antagonism in the effects of adenosine antagonists and L-NAME in the rat isolated heart.
Lewis CD; Hourani SM
Gen Pharmacol; 1997 Sep; 29(3):421-7. PubMed ID: 9378250
[TBL] [Abstract][Full Text] [Related]
9. Vasoconstriction increases pulmonary nitric oxide synthesis and circulating cyclic GMP.
Wilson PS; Thompson WJ; Moore TM; Khimenko PL; Taylor AE
J Surg Res; 1997 Jun; 70(1):75-83. PubMed ID: 9228932
[TBL] [Abstract][Full Text] [Related]
10. EDHF-mediated rapid restoration of hypotensive response to acetylcholine after chronic, but not acute, nitric oxide synthase inhibition in rats.
Desai KM; Gopalakrishnan V; Hiebert LM; McNeill JR; Wilson TW
Eur J Pharmacol; 2006 Sep; 546(1-3):120-6. PubMed ID: 16876156
[TBL] [Abstract][Full Text] [Related]
11. Pulmonary vasodilator responses to adrenomedullin are reduced by NOS inhibitors in rats but not in cats.
Nossaman BD; Feng CJ; Kaye AD; DeWitt B; Coy DH; Murphy WA; Kadowitz PJ
Am J Physiol; 1996 May; 270(5 Pt 1):L782-9. PubMed ID: 8967512
[TBL] [Abstract][Full Text] [Related]
12. NOS inhibition potentiates norepinephrine but not sympathetic nerve-mediated co-transmission in resistance arteries.
Smith KM; Macmillan JB; McCulloch KM; McGrath JC
Cardiovasc Res; 1999 Aug; 43(3):762-71. PubMed ID: 10690348
[TBL] [Abstract][Full Text] [Related]
13. Contribution of P1-(A2b subtype) and P2-purinoceptors to the control of vascular tone in the rat isolated mesenteric arterial bed.
Rubino A; Ralevic V; Burnstock G
Br J Pharmacol; 1995 Jun; 115(4):648-52. PubMed ID: 7582485
[TBL] [Abstract][Full Text] [Related]
14. Cerebral blood flow and cerebrovascular reactivity after inhibition of nitric oxide synthesis in conscious goats.
Fernández N; García JL; García-Villalón AL; Monge L; Gómez B; Diéguez G
Br J Pharmacol; 1993 Sep; 110(1):428-34. PubMed ID: 8220904
[TBL] [Abstract][Full Text] [Related]
15. Puerarin, an isoflavonoid derived from Radix puerariae, potentiates endothelium-independent relaxation via the cyclic AMP pathway in porcine coronary artery.
Yeung DK; Leung SW; Xu YC; Vanhoutte PM; Man RY
Eur J Pharmacol; 2006 Dec; 552(1-3):105-11. PubMed ID: 17027964
[TBL] [Abstract][Full Text] [Related]
16. Assessment of ability of levcromakalim and sodium nitroprusside to reverse the cardiovascular effects of nitric oxide synthase inhibition in the anaesthetised pig.
Herity NA; Allen JD; Silke B; Adgey AA
Cardiovasc Res; 1994 Jun; 28(6):894-900. PubMed ID: 7522965
[TBL] [Abstract][Full Text] [Related]
17. Comparison of effects of chronic and acute administration of NG-nitro-L-arginine methyl ester to the rat on inhibition of nitric oxide-mediated responses.
Bryant CE; Allcock GH; Warner TD
Br J Pharmacol; 1995 Apr; 114(8):1673-9. PubMed ID: 7541283
[TBL] [Abstract][Full Text] [Related]
18. Modulation of vasorelaxant responses to potassium channel openers by basal nitric oxide in the rat isolated superior mesenteric arterial bed.
McCulloch AI; Randall MD
Br J Pharmacol; 1996 Mar; 117(5):859-66. PubMed ID: 8851502
[TBL] [Abstract][Full Text] [Related]
19. Nitric oxide-dependent renal vasodilatation is not altered in rat with rHuEpo-induced hypertension.
Migliori M; Taccola D; Panichi V; De Pietro S; Andreini B; Di Benedetto A; Filippi C; Palla R; Giovannini L
Kidney Blood Press Res; 1999; 22(3):140-5. PubMed ID: 10394113
[TBL] [Abstract][Full Text] [Related]
20. Mesenteric vasodilator responses in cirrhotic rats: a role for nitric oxide?
Mathie RT; Ralevic V; Moore KP; Burnstock G
Hepatology; 1996 Jan; 23(1):130-6. PubMed ID: 8550032
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
